Page last updated: 2024-09-03

peroxynitrous acid and Bone Cancer

peroxynitrous acid has been researched along with Bone Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
BassiriRad, NM; Bui, L; Doyle, T; Forte, BL; Largent-Milnes, TM; Mantyh, PW; Neumann, WL; Salvemini, D; Slosky, LM; Staatz, WD; Symons, AM; Thompson, M; Vanderah, TW	1

Other Studies

1 other study(ies) available for peroxynitrous acid and Bone Cancer

Article	Year
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain. Pain, 2016, Volume: 157, Issue:11 Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiporters; Bone Neoplasms; Breast Neoplasms; Calcium-Binding Proteins; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Heterografts; Metalloporphyrins; Mice; Mice, Inbred BALB C; Peroxynitrous Acid; Sulfasalazine; Time Factors	2016

Article

Year

The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone pain.

Pain, 2016, Volume: 157, Issue:11

Topics: Adenocarcinoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiporters; Bone Neoplasms; Breast Neoplasms; Calcium-Binding Proteins; Cancer Pain; Cell Line, Tumor; Disease Models, Animal; Female; Gene Expression Regulation, Neoplastic; Glutamic Acid; Heterografts; Metalloporphyrins; Mice; Mice, Inbred BALB C; Peroxynitrous Acid; Sulfasalazine; Time Factors

2016